HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CTFA opposes FDA's proposed ban on color additive lakes formed in situ.

This article was originally published in The Rose Sheet

Executive Summary

FDA PROPOSED BAN ON IN SITU COLOR ADDITIVE LAKES OPPOSED BY CTFA in comments recently filed with the agency. "In situ color additive lakes provide shades of colors that cannot be produced through any other acceptable manufacturing process," the Cosmetic, Toiletry and Fragrance Association states. Their elimination "would require reformulation and label changes" for "thousands of product lines," as well as an "enormous level of industry manpower...to investigate alternative color additives and perform the necessary shade work," the trade association maintains.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS003336

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel